Expert Interview
A Second Look: Discussing BridgeBio/QED Therapeutics’ Oral Infigratinib Therapy for Children with Achondroplasia Ahead of the Phase 3 PROPEL 3 Readout
Ticker(s): BBIOInstitution: UT Southwestern Medical Center
- Associate Professor of Pediatrics and Pediatric Endocrinologist at UT Southwestern Medical Center
- Manages 30+ patients with achondroplasia. Treats hundreds of pediatric patients per year for growth, bone, and endocrine disorders through specialized pediatric endocrinology and genetics clinics.
- Specializes in caring for children with genetic growth disorders, skeletal dysplasias, bone health issues, and endocrinopathies related to neuromuscular and genetic conditions; leads and participates in clinical research and translational studies on novel therapeutics for achondroplasia, hypochondroplasia, Duchenne muscular dystrophy endocrinopathies, and other pediatric endocrine disorders.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
